Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma

Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma

Background: Chromosome 1p/19q codeletion is one of the most important genetic alterations for low grade gliomas (LGGs), and patients with 1p/19q codeletion have significantly prolonged survival compared to those without the codeletion. And the tumor immune microenvironment also plays a vital role in...

Full description

Bibliographic Details
Main Authors:	Lei Lv, Yuliu Zhang, Yujia Zhao, Qinqin Wei, Ye Zhao, Qiyi Yi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	low-grade glioma immune checkpoint genes tumor immune cell infiltration tumor immune microenvironment IDH mutation 1p/19q codeletion
Online Access:	https://www.frontiersin.org/articles/10.3389/fncel.2021.704344/full

Similar Items

Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma
by: Wanzun Lin, et al.
Published: (2021-06-01)

Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype
by: Teresa Cejalvo, et al.
Published: (2020-11-01)

CARD-Associated Risk Score Features the Immune Landscape and Predicts the Responsiveness to Anti-PD-1 Therapy in IDH Wild-Type Gliomas
by: Depei Li, et al.
Published: (2021-03-01)

Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted
by: Leomar Y. Ballester, et al.
Published: (2018-08-01)

Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas
by: Zenghui Qian, et al.
Published: (2018-06-01)

A radical shift in the diagnostic approach to diffuse gliomas
by: Rajesh Panth
Published: (2020-05-01)

IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice
by: Leland G. Richardson, et al.
Published: (2020-01-01)

Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts
by: Julieann Lee, et al.
Published: (2018-09-01)

Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment
by: Nan Zhang, et al.
Published: (2021-08-01)

Correlation Between Codeletion of Chromosome 1p/19q and MGMT Promoter Methylation in Oligodendrogliomas
by: GONG Huilin, et al.
Published: (2018-08-01)

Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas
by: Kenta Suzuki, et al.
Published: (2021-07-01)

Malignant Tumor Purity Reveals the Driven and Prognostic Role of CD3E in Low-Grade Glioma Microenvironment
by: Xiuqin Lu, et al.
Published: (2021-09-01)

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma
by: Xiaoshuai Ji, et al.
Published: (2020-10-01)

MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas
by: Qinglong Guo, et al.
Published: (2021-04-01)

A machine learning analysis of a “normal-like” IDH-WT diffuse glioma transcriptomic subgroup associated with prolonged survival reveals novel immune and neurotransmitter-related actionable targets
by: H. D. Nguyen, et al.
Published: (2020-10-01)

Classification of diffuse lower‐grade glioma based on immunological profiling
by: Fan Wu, et al.
Published: (2020-09-01)

Implications of IDH mutations on immunotherapeutic strategies for malignant glioma
by: Choi, B.D, et al.
Published: (2022)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
by: Xiangyang Deng, et al.
Published: (2019-11-01)

Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas
by: Shengchao Xu, et al.
Published: (2020-11-01)

Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics
by: Carlos G. Romo, et al.
Published: (2019-02-01)

Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma
by: Grant L. Lin, et al.
Published: (2018-06-01)

CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas
by: Ju Won Ahn, et al.
Published: (2020-09-01)

Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy
by: Hinda Najem, et al.
Published: (2021-08-01)

Prediction of 1p/19q Codeletion in Diffuse Glioma Patients Using Pre-operative Multiparametric Magnetic Resonance Imaging
by: Donnie Kim, et al.
Published: (2019-07-01)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
by: Wen Yin, et al.
Published: (2020-08-01)

Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
by: Joung, J.-G, et al.
Published: (2022)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
by: Shengchao Xu, et al.
Published: (2021-09-01)

A Focal Adhesion-Related Gene Signature Predicts Prognosis in Glioma and Correlates With Radiation Response and Immune Microenvironment
by: Haonan Li, et al.
Published: (2021-09-01)

Immunological classification of gliomas based on immunogenomic profiling
by: Qiushi Feng, et al.
Published: (2020-11-01)

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
by: Luyan Mu, et al.
Published: (2018-03-01)

Clinical Impact of Tumor-Infiltrating Lymphocytes and PD-L1-Positive Cells as Prognostic and Predictive Biomarkers in Urological Malignancies and Retroperitoneal Sarcoma
by: Makito Miyake, et al.
Published: (2020-10-01)

Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment
by: Etienne D. Foucher, et al.
Published: (2018-05-01)

Identification and Validation of an Immune-Associated RNA-Binding Proteins Signature to Predict Clinical Outcomes and Therapeutic Responses in Glioma Patients
by: Ruotong Tian, et al.
Published: (2021-04-01)

Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
by: Jun Su, et al.
Published: (2019-11-01)

EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study
by: Zhaonian Hao, et al.
Published: (2019-12-01)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
by: Xinzhuang Wang, et al.
Published: (2020-12-01)

Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment
by: Yuxiang Fan, et al.
Published: (2021-10-01)

Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins
by: Bozena Kaminska, et al.
Published: (2019-03-01)

Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma
by: Zhao JJ, et al.
Published: (2018-11-01)

Domain Mapping and Deep Learning from Multiple MRI Clinical Datasets for Prediction of Molecular Subtypes in Low Grade Gliomas
by: Muhaddisa Barat Ali, et al.
Published: (2020-07-01)